AVXL
Anavex Life Sciences Corp
2.40$
-4.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +110.4% | -38.6% | +193.1% | -12.4% | +3.9% | +36.4% | +367.9% | -5.5% | +1.1% | -12.2% | -23.4% | |
| – | +110.4% | -38.9% | +194.1% | -12.5% | +4.1% | +36.4% | +367.9% | -5.5% | +1.1% | -12.2% | -23.4% | |
| – | +110.6% | -39.9% | +198.7% | -16.4% | -3.2% | +31.8% | +420.0% | -1.9% | +1.3% | -12.5% | -22.4% | |
| – | +110.6% | -39.9% | +198.7% | -16.4% | -3.2% | +31.8% | +420.0% | -1.9% | +1.3% | -12.5% | -22.4% | |
| – | +0.0% | +3.3% | -87.7% | +19,087.1% | +41.3% | +83.5% | +88.4% | -65.1% | -15.2% | -9.6% | -67.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -44.4% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -62.8% | +19.9% | +12.3% | +8.4% | +29.7% | +45.0% | +47.8% | -5.4% | +22.7% | +22.1% | -41.5% | |
| – | +84.6% | +19.9% | +12.3% | +8.4% | +29.7% | +45.0% | +47.8% | -5.4% | +22.7% | +22.1% | -41.5% | |
| – | -55.6% | – | – | – | – | – | – | – | – | – | – | |
| – | +102.4% | +23.9% | +17.1% | -17.5% | +19.2% | +13.2% | +18.8% | -19.3% | +13.0% | +122.7% | -55.9% | |
| – | -99.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +6,549.7% | -50.8% | +284.5% | -15.5% | -1.0% | +34.2% | +453.7% | -5.5% | -0.4% | -15.2% | -21.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89.5% | +89.1% | +16.2% | +9.3% | +9.5% | +19.0% | +19.9% | +10.2% | +3.7% | +4.6% | +2.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.